These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 25342294

  • 1. Severe resistant hypocalcemia in multiple myeloma after zoledronic acid administration: a case report.
    Noriega Aldave AP, Jaiswal S.
    J Med Case Rep; 2014 Oct 23; 8():353. PubMed ID: 25342294
    [Abstract] [Full Text] [Related]

  • 2. Hypocalcemia Secondary to Zoledronate Therapy in a Patient With Low Vitamin D Level.
    Epperla N, Pathak R.
    WMJ; 2015 Aug 23; 114(4):163-6; quiz 167. PubMed ID: 26436186
    [Abstract] [Full Text] [Related]

  • 3. Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
    Henley D, Kaye J, Walsh J, Cull G.
    Intern Med J; 2005 Dec 23; 35(12):726-8. PubMed ID: 16313549
    [Abstract] [Full Text] [Related]

  • 4. Symptomatic intracranial hypertension and prolonged hypocalcemia following treatment of Paget's disease of the skull with zoledronic acid.
    Ferraz-de-Souza B, Martin RM, Correa PH.
    J Bone Miner Metab; 2013 May 23; 31(3):360-5. PubMed ID: 23076294
    [Abstract] [Full Text] [Related]

  • 5. Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient.
    Mishra A.
    J Postgrad Med; 2008 May 23; 54(3):237. PubMed ID: 18626181
    [No Abstract] [Full Text] [Related]

  • 6. Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern.
    Kaur U, Chakrabarti SS, Gambhir IS.
    Curr Drug Saf; 2016 May 23; 11(3):267-9. PubMed ID: 27113952
    [Abstract] [Full Text] [Related]

  • 7. Symptomatic hypocalcaemia after treatment with zoledronic acid in a patient with multiple myeloma.
    Singh D, Khaira NS, Sekhon JS.
    Ann Oncol; 2004 Dec 23; 15(12):1848. PubMed ID: 15550594
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors contributing to the development of hypocalcemia after zoledronic acid administration in patients with bone metastases of solid tumor.
    Hanamura M, Iwamoto T, Soga N, Sugimura Y, Okuda M.
    Biol Pharm Bull; 2010 Dec 23; 33(4):721-4. PubMed ID: 20410614
    [Abstract] [Full Text] [Related]

  • 9. Tonic-clonic seizure as the presentation symptom of severe hypocalcemia secondary to zoledronic acid administration.
    Navarro M, López R, Alaña M, Ocaña A, Leno R, Sánchez F, Fonseca E, Cruz JJ.
    J Palliat Med; 2007 Dec 23; 10(6):1226-7. PubMed ID: 18095793
    [No Abstract] [Full Text] [Related]

  • 10. Symptomatic hypocalcemia following a single dose of zoledronic acid in a patient with bone metastases secondary to breast cancer.
    Sözel H, Yilmaz F.
    J Oncol Pharm Pract; 2021 Mar 23; 27(2):494-497. PubMed ID: 32660376
    [Abstract] [Full Text] [Related]

  • 11. Severe increase in creatinine with hypocalcaemia in thalidomide-treated myeloma patients receiving zoledronic acid infusions.
    Jones SG, Dolan G, Lengyel K, Myers B.
    Br J Haematol; 2002 Nov 23; 119(2):576-7. PubMed ID: 12406106
    [No Abstract] [Full Text] [Related]

  • 12. Post-surgery severe hypocalcemia in primary hyperparathyroidism preoperatively treated with zoledronic acid.
    Corsello SM, Paragliola RM, Locantore P, Ingraudo F, Ricciato MP, Rota CA, Senes P, Pontecorvi A.
    Hormones (Athens); 2010 Nov 23; 9(4):338-42. PubMed ID: 21112866
    [Abstract] [Full Text] [Related]

  • 13. First cases of calcium pyrophosphate deposition disease after zoledronic acid therapy.
    Couture G, Delzor F, Bagheri H, Micallef J, Ruyssen-Witrand A, Laroche M.
    Joint Bone Spine; 2017 Mar 23; 84(2):213-215. PubMed ID: 27939801
    [Abstract] [Full Text] [Related]

  • 14. Persistent hypocalcemia induced by zoledronic acid in a patient with androgen-independent prostate cancer and extensive bone metastases.
    Gulley JL, Wu S, Arlen PM, Dahut WL.
    Clin Genitourin Cancer; 2007 Sep 23; 5(6):403-5. PubMed ID: 17956715
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prolonged hypocalcemia after zoledronic acid in a patient with metastatic prostate carcinoma: did zoledronic acid trigger osteoblastic activity and avid calcium uptake?
    Ho JW, Sundar S.
    Clin Genitourin Cancer; 2012 Mar 23; 10(1):50-3. PubMed ID: 22245101
    [No Abstract] [Full Text] [Related]

  • 18. Zoledronic acid-induced severe hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.
    Patel K, Brahmbhatt V, Ramu V.
    Tenn Med; 2005 Feb 23; 98(2):83-5, 89. PubMed ID: 15779196
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.